GloPID-R is pleased to welcome the Netherlands Organisation for Health Research and Development (ZonMw), represented by Suzanne Verver, into the network.
ZonMw funds health research in the Netherlands and promotes the practical application of the knowledge that this research produces. While mainly focused on research projects within the country, it also has an international focus through its participation in various European initiatives, including Joint Programming Initiatives (JPIs), ERA-NETs, and the European Strategy Forum on Research Infrastructures (ESFRI). ZonMw also participates in Heads of International Research Organisations (HIROs) to discuss large, international health care themes. By joining GloPID-R, ZonMw intends to expand its international collaboration on emerging infectious diseases.
Nationally, ZonMw runs a program on infectious disease control, including non-alimentary zoonoses, and emerging infectious disease research is an important part of this program. The program funds currently around 40 large research projects, including projects on HIV, tuberculosis, hepatitis C, STIs, pneumonia, vaccine preventable diseases, infection control, arboviruses, Lyme disease, campylobacter, rabies, Zika, tick-borne diseases, psittacosis and clostridium difficile.
Running a national research program on antibacterial resistance (ABR), ZonMw is also partner of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) Strategic Research Agenda, who also collaborates with GloPID-R. ZonMw finances many national projects studying ABR such as alternative ways to reduce antibiotic use in animals and human-animal ABR transmission.
ZonMw runs separate programs for antimicrobial resistance (AMR) and other aspects of infectious diseases. For these programs, the aim is to cover the entire spectrum of research from science to policy and through a One Health approach.
Despite being a new member, ZonMw has jumped right in and has already participated in the GloPID-R Data Sharing working group. GloPID-R appreciates their participation and looks forward to learning more from the organization’s scientific expertise.Back